US Stock MarketDetailed Quotes

INCY Incyte

Watchlist
  • 65.870
  • +0.500+0.76%
Close Jul 19 16:00 ET
  • 65.970
  • +0.100+0.15%
Pre 06:28 ET
12.98BMarket Cap19.96P/E (TTM)

Incyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Incyte Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Jul 30, 2024

Revenue(YoY)

1.01B

+5.61%
EPS(YoY)

0.84

-7.01%
Analyst Rating

Buy

Jul 21, 2024

Incyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.056B--
Jul 30, 20242024/Q2-- / 1.008B--
Apr 30, 20242024/Q1880.889M / 924.642M--
Feb 13, 20242023/Q41.013B / 1.003B--
Oct 31, 20232023/Q3919.025M / 963.400M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.056B--
Jul 30, 20242024/Q2-- / 1.008B--
Apr 30, 20242024/Q1880.889M / 924.642M--
Feb 13, 20242023/Q41.013B / 1.003B--
Oct 31, 20232023/Q3919.025M / 963.400M--

Unlock Free Earnings Estimates

Incyte Earnings Reports

  • Incyte | 10-Q: Quarterly report

    Apr 30 16:58 ET

  • Incyte | 10-K/A: Annual report (Amendment)

    Feb 16 16:08 ET

  • Incyte | 10-K: Annual report

    Feb 13 22:15 ET

  • Incyte | 10-Q: Q3 2023 Earnings Report

    Oct 31, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 21, 2024

    Buy

    • Buy

      50.00%

    • Hold

      41.67%

    • Sell

      8.33%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept CAR-T Therapy
    CAR-T Therapy
    Intraday-0.31%